5-MeO-DMT
Selected indexed studies
- A narrative synthesis of research with 5-MeO-DMT. (J Psychopharmacol, 2022) [PMID:34666554]
- 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk? (Psychopharmacology (Berl), 2025) [PMID:38072874]
- The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). (J Neurochem, 2022) [PMID:35149998]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A narrative synthesis of research with 5-MeO-DMT. (2022) pubmed
- 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk? (2025) pubmed
- The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). (2022) pubmed
- 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice. (2023) pubmed
- Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury. (2025) pubmed
- Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment. (2024) pubmed
- Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness. (2025) pubmed
- Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice. (2025) pubmed
- 5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study. (2023) pubmed
- Orally Active Forms of DMT, 5-MeO-DMT, and Long-Acting MDMA for the Treatment of Neuropsychiatric Disorders. (2023) pubmed